Comparative diagnostic performance of the new chromatographic Affimer®-based rapid antigen detection against SARS-CoV-2 and other standard antigen tests for COVID-19 in a clinical setting

A.I. Gil-Garcia, A. Lopez-Lopez, J.M. Rubio, J.J. Montoya, Y. Ouahid, A. Madejon, P. Castan
doi: https://doi.org/10.1101/2022.01.18.22269401

Data Availability

The study was completed under the frame of Project SENSORNAS RTC-20176501 in collaboration with MiRNAX Biosens Ltd. and Hospital Carlos III, including a total of 100 samples (50 negatives and 50 positives), each test was documented internally and deposited in agreement to the ISO 13485 norm.

Back to top
Posted January 26, 2022.
Download PDF
Data/Code
Email
Comparative diagnostic performance of the new chromatographic Affimer®-based rapid antigen detection against SARS-CoV-2 and other standard antigen tests for COVID-19 in a clinical setting
A.I. Gil-Garcia, A. Lopez-Lopez, J.M. Rubio, J.J. Montoya, Y. Ouahid, A. Madejon, P. Castan
medRxiv 2022.01.18.22269401; doi: https://doi.org/10.1101/2022.01.18.22269401
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area